189
Results-
Press ReleasePierre Fabre Laboratories receives the Galien International Prize for EBVALLO®Created on : - Last modified on :Pierre Fabre Laboratories receives the Galien International Prize for EBVALLO®, the first allogeneic immunotherapy for patients with a rare cancer
-
Press ReleasePierre Fabre Laboratoires signs a sponsorship agreement with the IHU healthAge In ToulouseCreated on : - Last modified on :Pierre Fabre Laboratories signs a sponsorship agreement with the IHU HealthAge in Toulouse to identify new biological mechanisms underlying skin aging. Toulouse, July 11, 2024 - Committed to understanding and addressing skin aging, Pierre Fabre Laboratories are extending their longstanding support to the University Hospital Center (CHU) of Toulouse and the teams led by Professor Bruno VELLAS, founding President of the Hospital-University Institute (IHU) HealthAge, through the signing of a five-year sponsorship agreement.
-
Press ReleasePierre Fabre & Scorpion Therapeutics announce new Phase I/II clinical trial for an innovative treatment in oncology.Created on : - Last modified on :Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer Driven by EGFR Exon 19 or 21 and Co-occurring C797S Mutations PFL-241/STX-241 is a highly selective, and potentially best-in-class fourth generation epidermal growth factor receptor (“EGFR”) inhibitor One of two EGFR programs being developed with Scorpion Therapeutics
-
Press ReleaseDosing of the first patient in the phase I/II trial evaluating PFL-002/VERT-002, a targeted therapy in oncologyCreated on : - Last modified on :PFL-002/VERT-002 is a monoclonal antibody with a novel and differentiated mechanism of action, acting as a degrader of c-MET, with the potential to be a best-in-class treatment for cancer driven by MET alterations
-
Press ReleaseExceptional Natural Disaster in Mayotte: The Pierre Fabre Foundation releases emergency aidCreated on : - Last modified on :The passage of Cyclone Chido over the Mayotte archipelago on December 14 has been an unprecedented natural disaster. More than 100,000 people living in precarious housing have seen their homes completely destroyed. There is an urgent need to address essential requirements: water, food, debris clearance, and medical care. Given the scale of the disaster, the Fondation Pierre Fabre has decided to provide support amounting to €100,000 to address these urgent needs.
-
Press ReleasePierre Fabre Laboratories sells its immuno-oncology research site located in Saint-Julien-en-Genevois (Haute-Savoie) to Jubilant Biosys LimitedCreated on : - Last modified on :Castres, January 29, 2025 – Pierre Fabre Laboratories and Jubilant Biosys Limited have signed an agreement regarding the sale of the Pierre Fabre research and development site specialized in immuno-oncology located in Saint-Julien-en-Genevois, following the announcement of entering into exclusive negotiations made last August 19.
-
Press ReleasePierre Fabre & Avène launch MySun Experience, a simulator to revolutionize the prevention of sun-related skin agingCreated on : - Last modified on :The tool confirms that the correct use of a sun product (SPF30+) could reduce photoaging by up to 50% in some cases. In 15 years, it will be possible to reduce photoaging for people who follow the prevention advice of the tool: . by 6 years for a 24-year-old French woman with fair skin,
-
Websites aimed at health care professionalsCreated on : - Last modified on :Websites aimed at health care professionals DERMAWEBDermaweb is a professional dermatology information and discussion website ENTRETIENS D'AVENEThis website offers interviews for a scientific audience, with the aim of keeping them up to date on the latest dermatology news
-
Our CommitmentsCreated on : - Last modified on :
-
NewsJavier Prieto Freire: A Medical Science Liaison (MSL) Committed to Elevating Medical Standards in SpainCreated on : - Last modified on :The script of video.
We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.